Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?

被引：16
作者：
Hasselbalch, Hans Carl [1 ]
机构：
[1] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark
来源：
HAEMATOLOGICA | 2019年 / 104卷 / 11期
关键词：
MUTATION STATUS; CRITERIA; CLASSIFICATION; NEOPLASMS; DISEASE; JAK2; MECHANISMS; RISK; REPRODUCIBILITY; ERYTHROCYTOSIS;
D O I：
10.3324/haematol.2019.229039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2119 / 2125
页数：8
相关论文
共 62 条
[21]   Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms [J].
Gianelli, Umberto ;
Iurlo, Alessandra ;
Cattaneo, Daniele ;
Lambertenghi-Deliliers, Giorgio .
EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (02) :255-264
[22]   Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera [J].
Gisslinger, Heinz ;
Zagrijtschuk, Oleh ;
Buxhofer-Ausch, Veronika ;
Thaler, Josef ;
Schloegl, Ernst ;
Gastl, Guenther A. ;
Wolf, Dominik ;
Kralovics, Robert ;
Gisslinger, Bettina ;
Strecker, Karin ;
Egle, Alexander ;
Melchardt, Thomas ;
Burgstaller, Sonja ;
Willenbacher, Ella ;
Schalling, Martin ;
Them, Nicole C. ;
Kadlecova, Pavla ;
Klade, Christoph ;
Greil, Richard .
BLOOD, 2015, 126 (15) :1762-1769
[23]   Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis [J].
Gordeuk, Victor R. ;
Key, Nigel S. ;
Prchal, Josef T. .
HAEMATOLOGICA, 2019, 104 (04) :653-658
[24]   Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure? [J].
Hasselbalch, Hans Carl ;
Holmstroem, Morten Orebo .
SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (01) :5-19
[25]  
Hoogeveen RM, 2018, EUR HEART J, V39, P3521, DOI [10.1093/eurheartj/ehx581, 10.1093/eurheartj/ehx703]
[26]   The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology [J].
Jakovic, Ljubomir ;
Gotic, Mirjana ;
Gisslinger, Heinz ;
Soldatovic, Ivan ;
Sefer, Dijana ;
Tirnanic, Mila ;
Lekovic, Danijela ;
Jovanovic, Maja Perunicic ;
Schalling, Martin ;
Gisslinger, Bettina ;
Beham-Schmid, Christine ;
Simonitsch-Klupp, Ingrid ;
Thiele, Juergen .
ANNALS OF HEMATOLOGY, 2018, 97 (09) :1581-1590
[27]   An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia [J].
Johansson, PL ;
Safai-Kutti, S ;
Kutti, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) :701-705
[28]   hemoglobin and the Risk of Cerebral infarction: The Framinglam Study [J].
Kannel, William B. ;
Gordon, Tavia ;
Wolf, Philip A. ;
McNamara, Patricia .
STROKE, 1972, 3 (04) :409-420
[29]   European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia [J].
Kvasnicka, Hans Michael ;
Orazi, Attilio ;
Thiele, Juergen ;
Barosi, Giovanni ;
Bueso-Ramos, Carlos E. ;
Vannucchi, Alessandro M. ;
Hasserjian, Robert P. ;
Kiladjian, Jean-Jacques ;
Gianelli, Umberto ;
Silver, Richard ;
Mughal, Tariq I. ;
Barbui, Tiziano .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) :1062-1067
[30]   WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update [J].
Kvasnicka, Hans Michael .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (04) :333-341
1234567